{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:00:15Z","timestamp":1780923615424,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.urolonc.2026.04.298","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:35:51Z","timestamp":1779449751000},"page":"391-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-7096","authenticated-orcid":false,"given":"Luis G.","family":"Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo Storino","family":"Ramacciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Halteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Aron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duke K.","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ukimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderbir S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Luis","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.urolonc.2026.04.298_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.29760","article-title":"Trends in active surveillance for men with intermediate-risk prostate cancer","volume":"7","author":"Diven","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.urolonc.2026.04.298_bib0002","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3390\/curroncol31070270","article-title":"Salvage high-intensity focused ultrasound for prostate cancer after radiation failure: a narrative review","volume":"31","author":"Sobhani","year":"2024","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.04.298_bib0003","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.04.298_bib0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eururo.2021.10.005","article-title":"Focal therapy for prostate cancer: getting ready for prime time","volume":"81","author":"Abreu","year":"2022","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.urolonc.2026.04.298_bib0005","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.21037\/tcr-24-245","article-title":"Management strategies for radio-recurrent prostate cancer: a comprehensive review","volume":"13","author":"Rahman","year":"2024","journal-title":"Transl Cancer Res"},{"issue":"4","key":"10.1016\/j.urolonc.2026.04.298_bib0006","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/Astro\/Suo guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"issue":"14","key":"10.1016\/j.urolonc.2026.04.298_bib0007","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.3390\/cancers15143734","article-title":"The role of salvage radical prostatectomy in patients with radiation-resistant prostate cancer","volume":"15","author":"Drobner","year":"2023","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.urolonc.2026.04.298_bib0008","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/cancers16152717","article-title":"Salvage cryoablation for recurrent prostate cancer following radiation\u2014a comprehensive review","volume":"16","author":"Lee","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.urolonc.2026.04.298_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.euros.2023.02.003","article-title":"Patient-reported satisfaction and regret following focal therapy for prostate cancer: a prospective multicenter evaluation","volume":"50","author":"Ghoreifi","year":"2023","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"10.1016\/j.urolonc.2026.04.298_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2023.06.013","article-title":"Primary whole-gland ablation for the treatment of clinically localized prostate cancer: a focal therapy society best practice statement","volume":"84","author":"Deivasigamani","year":"2023","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.04.298_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.01.011","article-title":"Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer","volume":"39","author":"Chesnut","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.04.298_bib0012","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.eururo.2015.12.015","article-title":"Focal therapy for prostate cancer: an \u201c\u00c0 la carte\u201d approach","volume":"69","author":"Sivaraman","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.04.298_bib0013","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/bju.12151","article-title":"Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy","volume":"112","author":"De Castro Abreu","year":"2013","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2026.04.298_bib0014","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bju.12795","article-title":"Real-time transrectal ultrasonography-guided hands-free technique for focal cryoablation of the prostate","volume":"114","author":"De Castro Abreu","year":"2014","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.urolonc.2026.04.298_bib0015","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/JU.0000000000000456","article-title":"Hemigland cryoablation of localized low, intermediate and high risk prostate cancer: oncologic and functional outcomes at 5 years","volume":"202","author":"Oishi","year":"2019","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.04.298_bib0016","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/JU.0000000000001126","article-title":"High intensity focused ultrasound hemigland ablation for prostate cancer: initial outcomes of a United States series","volume":"204","author":"Abreu","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.04.298_bib0017","series-title":"Interventional oncology","first-page":"1","article-title":"High-intensity focused ultrasound (HIFU) for prostate cancer","author":"Kaneko","year":"2025"},{"issue":"4","key":"10.1016\/j.urolonc.2026.04.298_bib0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","article-title":"Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience","volume":"81","author":"Reddy","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.04.298_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.0.CO;2-2","article-title":"Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma","volume":"79","author":"Crook","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2026.04.298_bib0020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.04.298_bib0021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.urolonc.2026.04.298_bib0022","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.04.298_bib0023","article-title":"Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: a multicenter retrospective study","volume":"39","author":"Marra","year":"2021","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"11","key":"10.1016\/j.urolonc.2026.04.298_bib0024","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00345-016-1811-9","article-title":"Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review","volume":"34","author":"Duijzentkunst","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.04.298_bib0025","article-title":"Salvage treatments after focal therapy for prostate cancer: a comprehensive review","author":"Storino Ramacciotti","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2026.04.298_bib0026","article-title":"Androgen deprivation therapy, cardiovascular risk, and mortality in black prostate cancer patients: challenging established beliefs?","author":"Biasatti","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.urolonc.2026.04.298_bib0027","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1245\/s10434-015-4686-x","article-title":"Comparisons of oncological and functional outcomes between primary whole-gland cryoablation and high-intensity focused ultrasound for localized prostate cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.04.298_bib0028","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.urology.2022.05.060","article-title":"Minimally invasive management of rectourethral fistulae","volume":"169","author":"Medina","year":"2022","journal-title":"Urology"},{"issue":"4S","key":"10.1016\/j.urolonc.2026.04.298_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2018.02.1957","article-title":"PD42-04 Outcomes of salvage robot-assisted radical prostatectomy post primary radiation and thermal ablation therapies","volume":"199","author":"Mekhail","year":"2018","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.04.298_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/bco2.70019","article-title":"The outcomes of salvage robotic radical prostatectomy following radiation versus focal therapy: does the primary treatment modality matter?","volume":"6","author":"Ghoreifi","year":"2025","journal-title":"BJUI Compass"},{"issue":"2","key":"10.1016\/j.urolonc.2026.04.298_bib0031","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.urology.2012.09.033","article-title":"Preventing perioperative complications of robotic-assisted radical prostatectomy","volume":"81","author":"Liss","year":"2013","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:05:40Z","timestamp":1780920340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1078143926005041"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.04.298","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.04.298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}